Sponsor Pipeline

PharmaMar Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
1
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT07644039
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced…		 Trial sites expanded: 6 -> 11 locations
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06088290 Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as… Leiomyosarcoma Active, Not Recruiting
Phase 1/2
NCT07644039 Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced… Advanced Malignancies Recruiting
Phase 1
NCT05835609 PM534 Administered Intravenously to Patients With Advanced Solid Tumors Patients With Advanced Solid Tumors Recruiting
NCT05841563 Clinical Trial of PM54 in Advanced Solid Tumors Patients. Advanced Solid Tumor Recruiting
Disease Areas
Sarcoma (1)
Get alerts when PharmaMar's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free